-
1
-
-
0035666619
-
The pharmacovigilance of olanzapine: Results of a post-marketing surveillance study on 8858 patients in England
-
Biswas, P.N., Wilton, L.V., Pearce, G.L., Freemantle, S. and Shakir, S.A.W. (2001): The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England. J. Psychopharmacol., 15, 265-271.
-
(2001)
J. Psychopharmacol
, vol.15
, pp. 265-271
-
-
Biswas, P.N.1
Wilton, L.V.2
Pearce, G.L.3
Freemantle, S.4
Shakir, S.A.W.5
-
2
-
-
0032803911
-
Olanzapine overdose with serum concentrations
-
Cohen, L.G., Fatalo, A., Thompson, B.T., Di Centes Bergeron, G., Flood, J.G. and Poupolo, P.R. (1999): Olanzapine overdose with serum concentrations. Ann. Emerg. Med., 34, 275-278.
-
(1999)
Ann. Emerg. Med
, vol.34
, pp. 275-278
-
-
Cohen, L.G.1
Fatalo, A.2
Thompson, B.T.3
Di Centes Bergeron, G.4
Flood, J.G.5
Poupolo, P.R.6
-
3
-
-
0031016120
-
Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses
-
Fulton, B. and Goa, K.L. (1997): Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. Drugs, 53, 281-298.
-
(1997)
Drugs
, vol.53
, pp. 281-298
-
-
Fulton, B.1
Goa, K.L.2
-
4
-
-
0033838715
-
Overdose and death with olanzapine: Two case reports
-
Gerber, J.E. and Cawthon, B. (2000): Overdose and death with olanzapine: two case reports. Am. J. Forensic Med. Pathol., 21, 249-251.
-
(2000)
Am. J. Forensic Med. Pathol
, vol.21
, pp. 249-251
-
-
Gerber, J.E.1
Cawthon, B.2
-
5
-
-
34147092083
-
Serum levels of olanzapine in a non-fatal overdose
-
Lennestål, R., Asplund, C., Nilsson, M., Lakso, H., Mjörndal, T. and Hägg, S. (2007): Serum levels of olanzapine in a non-fatal overdose. J. Anal. Toxicol., 31,119-121.
-
(2007)
J. Anal. Toxicol
, vol.31
, pp. 119-121
-
-
Lennestål, R.1
Asplund, C.2
Nilsson, M.3
Lakso, H.4
Mjörndal, T.5
Hägg, S.6
-
6
-
-
34447316364
-
A review of atypical antipsychotic drugs versus conventional medication in schizophrenia
-
Luft, B. and Taylor, D. (2006): A review of atypical antipsychotic drugs versus conventional medication in schizophrenia. Expert Opin. Pharmacother., 7, 1739-1748.
-
(2006)
Expert Opin. Pharmacother
, vol.7
, pp. 1739-1748
-
-
Luft, B.1
Taylor, D.2
-
7
-
-
34147115525
-
Olanzapine overdose: A series of analytically confirmed cases
-
Morgan, M., Hackett, L.P. and Isbister, G.K. (2007): Olanzapine overdose: a series of analytically confirmed cases. Int. Clin. Psychopharmacol., 22, 183-186.
-
(2007)
Int. Clin. Psychopharmacol
, vol.22
, pp. 183-186
-
-
Morgan, M.1
Hackett, L.P.2
Isbister, G.K.3
-
8
-
-
0032779307
-
Olanzapine overdose mimicking opioid intoxication
-
O'Malley, G.F., Seifert, S., Heard, K., Daly, F. and Dart, R.C. (1999): Olanzapine overdose mimicking opioid intoxication. Ann. Emerg. Med., 34, 279-281.
-
(1999)
Ann. Emerg. Med
, vol.34
, pp. 279-281
-
-
O'Malley, G.F.1
Seifert, S.2
Heard, K.3
Daly, F.4
Dart, R.C.5
-
9
-
-
1842429031
-
The clinical picture of olanzapine poisoning with special reference to fluctuating mental status
-
Palenzona, S., Meier, P.J., Kupferschmidt, H. and Rauber-Luethy, C. (2004): The clinical picture of olanzapine poisoning with special reference to fluctuating mental status. J. Toxicol. Clin. Toxicol., 42, 27-32.
-
(2004)
J. Toxicol. Clin. Toxicol
, vol.42
, pp. 27-32
-
-
Palenzona, S.1
Meier, P.J.2
Kupferschmidt, H.3
Rauber-Luethy, C.4
-
10
-
-
33847406614
-
Impact of legislative changes on patterns of antipsychotic prescribing and self-poisoning in Scotland: 2000-06
-
Poon, H., Elliot, V., Bateman, D.N. and Waring, W.S. (2007): Impact of legislative changes on patterns of antipsychotic prescribing and self-poisoning in Scotland: 2000-06. J. Toxicol. Sci., 32, 1-7.
-
(2007)
J. Toxicol. Sci
, vol.32
, pp. 1-7
-
-
Poon, H.1
Elliot, V.2
Bateman, D.N.3
Waring, W.S.4
-
11
-
-
35148849700
-
Pharmacokinetic consideration in clinical toxicology: Clinical applications
-
Roberts, D.M. and Buckley, N.A. (2007): Pharmacokinetic consideration in clinical toxicology: clinical applications. Clin. Pharmacokinetics, 46, 897-939.
-
(2007)
Clin. Pharmacokinetics
, vol.46
, pp. 897-939
-
-
Roberts, D.M.1
Buckley, N.A.2
-
12
-
-
0034061823
-
Olanzapine concentrations in clinical serum and postmortem blood specimens: When does therapeutic become toxic?
-
Robertson, M.D. and McMullin, M.M. (2000) Olanzapine concentrations in clinical serum and postmortem blood specimens: when does therapeutic become toxic? J. Forensic Sci., 45, 418-421.
-
(2000)
J. Forensic Sci
, vol.45
, pp. 418-421
-
-
Robertson, M.D.1
McMullin, M.M.2
-
13
-
-
29944442844
-
Olanzapine overdose in children and adolescents: Two case reports and a review of the literature
-
Theisen, F.M., Grabarkiewicz, J., Fegbeutel, C., Hübner, A., Mehler-Wex, C. and Remschmidt, H. (2005): Olanzapine overdose in children and adolescents: two case reports and a review of the literature. J. Child Adolesc. Psychopharmacol., 15, 986-95.
-
(2005)
J. Child Adolesc. Psychopharmacol
, vol.15
, pp. 986-995
-
-
Theisen, F.M.1
Grabarkiewicz, J.2
Fegbeutel, C.3
Hübner, A.4
Mehler-Wex, C.5
Remschmidt, H.6
-
14
-
-
33846212687
-
Olanzapine overdose is associated with acute muscle toxicity
-
Waring, W.S., Wrate, J. and Bateman, D.N. (2006): Olanzapine overdose is associated with acute muscle toxicity. Hum. Exp. Toxicol., 25, 735-40.
-
(2006)
Hum. Exp. Toxicol
, vol.25
, pp. 735-740
-
-
Waring, W.S.1
Wrate, J.2
Bateman, D.N.3
|